Projects per year
Personal profile
Campus career
附属病院 特命准教授 2015/08/01-2019/09/30
附属病院 特命准教授 2019/10/01-2023/01/31
医学系 特命准教授 2019/10/01-2023/01/31
附属病院 准教授 2023/02/01-
医学系 准教授 2023/02/01-
医学部医学科 基幹教員
学部運営への参画状況・・・有-医学科医学教育推進専門委員会
担当授業科目に係る状況・・・主要授業科目担当
Research Fields, Keywords
- Pulmonology
Field of expertise (Grants-in-aid for Scientific Research classification)
- Respiratory organ internal medicine
Fingerprint
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Active
-
Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients With a Poor Performance Status or Higher Neutrophil/Lymphocyte Ratio
Inomata, M., Takata, N., Seto, Z., Murayama, N., Tokui, K., Okazawa, S., Imanishi, S., Miwa, T., Hayashi, R. & Matsui, S., 2025/01, In: In Vivo. 39, 1, p. 467-472 6 p.Research output: Contribution to journal › Article › peer-review
-
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma
Tsuda, T., Ichikawa, T., Matsumoto, M., Mizusihima, I., Azechi, K., Takata, N., Murayama, N., Hayashi, K., Hirai, T., Seto, Z., Tokui, K., Masaki, Y., Taka, C., Okazawa, S., Kambara, K., Imanishi, S., Taniguchi, H., Miwa, T., Hayashi, R. & Matsui, S. & 1 others, , 2024/12, In: Discover Oncology. 15, 1, 382.Research output: Contribution to journal › Article › peer-review
Open Access -
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers
NOVELTY Scientific Community & NOVELTY study Investigators, 2024/04, In: Journal of Allergy and Clinical Immunology: In Practice. 12, 4, p. 970-982 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparing the effectiveness of afatinib and osimertinib for patients with pd-l1-positive egfr-mutant non-small cell carcinoma
Inomata, M., Kawashima, Y., Saito, R., Morinaga, D., Nogawa, H., Sato, M., Suzuki, Y., Yanagisawa, S., Kikuchi, T., Jingu, D., Yoshimura, N., Harada, T. & Miyauchi, E., 2024, In: Cancer Diagnosis and Prognosis. 4, 4, p. 515-520 6 p.Research output: Contribution to journal › Article › peer-review
-
Comparison of the efficacy of first-/second-generation EGFR-tyrosine kinase inhibitors and osimertinib for EGFR-mutant lung cancer with negative or low PD-L1 expression
Inomata, M., Minatoyama, S., Takata, N., Hayashi, K., Hirai, T., Seto, Z., Tokui, K., Taka, C., Okazawa, S., Kambara, K., Imanishi, S., Miwa, T., Hayashi, R., Matsui, S. & Tobe, K., 2024, In: Molecular and Clinical Oncology. 20, 6, 43.Research output: Contribution to journal › Article › peer-review
Activities
- 16 Oral presentation
-
Thoracic Paravertebral Lesions in Patients with IgG4-Related Respiratory Disease
Inomata, M. (Speaker)
2019/05/17 → 2019/05/22Activity: Talk or presentation › Oral presentation
-
CT Findings Reduce the Risk of EBUS-TBNA
Inomata, M. (Speaker)
2017/10/15 → 2017/10/18Activity: Talk or presentation › Oral presentation
-
シスプラチン含有化学療法におけるカルニチン動態と倦怠感の関連(がん薬物療法(他の副作用対策)2,ポスター,一般演題,医療薬学の進歩と未来-次の四半世紀に向けて-)
Inomata, M. (Speaker)
2015/11/21 → 2015/11/23Activity: Talk or presentation › Oral presentation
-
新旧ナビゲーションの機能比較について : Bf-NAVIとDirectPath(末梢肺癌の診断1,Oralセッション)
Inomata, M. (Speaker)
2015/06/11 → 2015/06/12Activity: Talk or presentation › Oral presentation
-
EBUS-GSで診断可能であった肺真菌症症例の検討(内科症例6,ポスターセッション)
Inomata, M. (Speaker)
2015/06/11 → 2015/06/12Activity: Talk or presentation › Oral presentation